A Democratic-led push to study replacing California's gas tax with a per-mile road usage charge has ignited fierce Republican opposition, framing the debate as a critical test for infrastructure funding as fuel tax revenues decline nationwide.
While market volatility unnerves many savers, financial experts warn that an overly conservative investment strategy during one's prime earning years may pose a far greater long-term risk to retirement security.
A coalition of 43 state attorneys general has filed a sweeping lawsuit accusing pharmaceutical giant Novartis and its former subsidiary Sandoz of orchestrating a massive bid-rigging scheme for 31 generic drugs, calling it one of the most brazen conspiracies ever uncovered in the industry.
Panamanian President José Raúl Mulino has publicly rebuffed a stark warning from China following the eviction of a Hong Kong-based port operator, escalating a diplomatic row that underscores the broader U.S.-China rivalry for influence over the vital Panama Canal.
Precious metals markets have been rocked by unprecedented volatility, with gold and silver posting both historic drops and sharp recoveries within days. While long-term believers see a buying opportunity, the rollercoaster has left traders and advisors grappling with strategy.
In a significant economic development win, international engineering firm Mecad USA has chosen the Tulsa Port of Catoosa for its U.S. headquarters and a new advanced manufacturing facility, citing Oklahoma's infrastructure and energy policy reforms as key factors.
After a bruising year for its share price, Chipotle Mexican Grill's conservative 2026 targets are being viewed by some analysts as a strategic setup to exceed expectations and win back investor confidence.
In a sweeping strategic shift, The Washington Post is laying off approximately 300 journalists, dismantling its sports desk, and scaling back international and local coverage. The move, described by staff as a 'bloodbath,' marks a profound contraction for the storied publication under owner Jeff Bezos.
A single, massive investment of nearly $396 million has propelled State Street's once-struggling private credit ETF toward the half-billion-dollar mark, signaling a potential turning point for the fund.
While Eli Lilly's stock surged on weight-loss drug hype, its premium valuation prompts a look at undervalued rival Pfizer, which is pivoting its strategy after a pipeline setback.
A leaked internal memo reveals Cracker Barrel's guideline for traveling employees to dine primarily at its own restaurants, reigniting discussions on corporate cost-cutting and brand loyalty.
A new WalletHub analysis of 182 U.S. cities places Detroit among the lowest for household budgeting skills, highlighting stark contrasts in spending, credit, and savings behaviors across the nation.
In a major settlement with the Federal Trade Commission, Cigna's pharmacy benefit manager, Express Scripts, has agreed to overhaul its drug pricing practices, particularly for insulin, a move regulators estimate could save patients billions over the next decade.
Market volatility can test any investor's resolve. We analyze six monthly dividend ETFs designed to provide income and potential stability when markets turn south, examining their strategies, holdings, and historical performance.
As Qualcomm prepares to report Q1 FY2026 earnings, the chipmaker faces a pivotal moment. Mounting competition from Apple's in-house modems, a slowing handset market, and regulatory pressures in China have investors on edge, setting the stage for a report that could redefine the stock's trajectory.
Amid hazardous winter conditions, a police dog named Bo successfully located a 13-year-old boy with special needs who had wandered from his home without proper clothing, preventing a potential tragedy.
In a scathing critique, former executive editor Marty Baron lambasts owner Jeff Bezos's stewardship, linking strategic missteps to a wave of layoffs and diminished ambitions at the historic newspaper.
The iconic Hyannis plant, a tourist attraction and local employer since 1985, will shut its doors this April. Production shifts to Campbell's existing facilities, severing a tangible link to the brand's namesake region.
After years of steady but modest expansion, Johnson & Johnson projects a significant acceleration in revenue, driven by a bold ambition to dominate the global oncology market. With shares trading at a premium, analysts debate if the stock's future growth potential justifies its current price.
Bio-Techne's Q2 FY2026 results show flat organic revenue, as robust demand from large pharmaceutical clients countered persistent softness in the biotech and academic sectors. Management highlights strategic growth areas and expects gradual market improvement.
